small molecule

SODIUM IODIDE I 123

SODIUM IODIDE I-123

Loss of exclusivityloss of exclusivity
CompanyGE HEALTHCARE

Drug detail

Brand nameSODIUM IODIDE I 123
Active ingredientSODIUM IODIDE I-123
Strength200uCi
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 1993
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

SODIUM IODIDE I 123 patent cliff — loss of exclusivity — | CliffBio